According to a new market research report published by Meticulous Research, the CBD-infused products market is expected to reach a value of $291.39 billion by 2032, at a CAGR of 30.6% from 2025 to 2032.
The CBD-infused products market “is experiencing robust growth driven primarily by increasing consumer demand for cannabis products, expanding legalization across various jurisdictions, and growing popularity of cannabis-infused edibles”, states the report. However, “market expansion faces challenges from high production costs associated with cannabidiol (CBD) and regulatory restrictions in certain countries.”
Hemp is expected to account for 76.3% of the overall CBD-infused products market in 2025 and achieve the highest CAGR of 32.7% during the forecast period. This dominance is attributed to “hemp’s lower THC concentration, reduced psychoactive effects, and suitability for medical applications, along with its anti-inflammatory, anti-aging, and antioxidant properties.”
As far as product type, edibles are projected to hold the largest market share of the overall CBD-infused products market at 33.6% in 2025 and maintain the highest CAGR through 2032. Growth in this segment is primarily supported by increasing social acceptance of CBD-infused edibles and their expanding use in treating psychiatric disorders, neurological conditions, cancer, and pain management.
According to the report, major companies operating in the global CBD-infused products market include:
- Canopy Growth Corporation (Canada)
- Aurora Cannabis Inc. (Canada)
- Maricann Inc. (Canada)
- Tilray Brands, Inc. (Canada)
- GW Pharmaceuticals plc (U.K.)
- MediPharm Labs Corp. (Canada)
- Cresco Labs, Inc. (U.S.)
- Tauriga Sciences, Inc. (U.S.)
- MariMed Inc. (U.S.)
- CV Sciences, Inc. (U.S.)
- Kona Gold Beverage, Inc. (U.S.)
- Bhang Inc. (U.S.)
- DT Brands & Co (N.I.) Ltd. (U.S.)
- Irwin Naturals Inc. (U.S.)
- Hempstrol Pharma (India)
- Kapu Maku LLC. (U.S.)
- Medterra CBD, LLC. (U.S.)
- Endoca LLC (U.S.),
- Elixinol Global Limited (Australia)
North America is expected to dominate the global CBD-infused products market market with a 59.5% share in 2025 and achieve the highest CAGR of 34.3% through 2032. This regional leadership is supported by growing health and wellness trends, increased R&D investment, rising corporate funding, technological advancements in production and processing, and expansion of online retail channels.
More articles from The Marijuana Herald:
